These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 7875239

  • 1. Effects of activin A/erythroid differentiation factor on erythroid and megakaryocytic differentiations of mouse erythroleukemia (Friend) cells: evidence for two distinct modes of cell response.
    Okafuji K, Kaku K, Seguchi M, Tanaka H, Azuno Y, Kaneko T.
    Exp Hematol; 1995 Mar; 23(3):210-6. PubMed ID: 7875239
    [Abstract] [Full Text] [Related]

  • 2. Synergistic action of activin A and hexamethylene bisacetamide in differentiation of murine erythroleukemia cells.
    Yamashita T, Eto Y, Shibai H, Ogata E.
    Cancer Res; 1990 Jun 01; 50(11):3182-5. PubMed ID: 2334914
    [Abstract] [Full Text] [Related]

  • 3. Activin A/erythroid differentiation factor induces thromboxane A2 synthetic activity in murine erythroleukemia cells.
    Yamashita T, Shimizu T, Ogata E.
    J Biol Chem; 1991 Feb 25; 266(6):3888-92. PubMed ID: 1995639
    [Abstract] [Full Text] [Related]

  • 4. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T, Yamashita K, Ohashi H, Kagami Y, Tsushita K, Kinoshita T, Hotta T, Saito H, Yoshida S, Mori KJ.
    Exp Hematol; 1993 Jan 25; 21(1):169-76. PubMed ID: 8417953
    [Abstract] [Full Text] [Related]

  • 5. Inhibition by erythroid differentiation factor (activin A) of P-glycoprotein expression in multidrug-resistant human K562 erythroleukemia cells.
    Okabe-Kado J, Hayashi M, Honma Y, Hozumi M, Tsuruo T.
    Cancer Res; 1991 May 15; 51(10):2582-6. PubMed ID: 1673636
    [Abstract] [Full Text] [Related]

  • 6. Effects of erythroid differentiation factor (EDF) on proliferation and differentiation of human hematopoietic progenitors.
    Nakao K, Kosaka M, Saito S.
    Exp Hematol; 1991 Dec 15; 19(11):1090-5. PubMed ID: 1752318
    [Abstract] [Full Text] [Related]

  • 7. Activin A: a commitment factor in erythroid differentiation.
    Shiozaki M, Kosaka M, Eto Y.
    Biochem Biophys Res Commun; 1998 Jan 26; 242(3):631-5. PubMed ID: 9464268
    [Abstract] [Full Text] [Related]

  • 8. Inhibition by 1alpha,25-dihydroxyvitamin D3 of activin A-induced differentiation of murine erythroleukemic F5-5 cells.
    Nagasaki T, Hino M, Inaba M, Nishizawa Y, Morii H, Otani S.
    Arch Biochem Biophys; 1997 Jul 15; 343(2):181-7. PubMed ID: 9224728
    [Abstract] [Full Text] [Related]

  • 9. Constitutive expression of a megakaryocytic functional property by murine erythroleukemia (Friend) cells: the incorporation of serotonin.
    Vannucchi AM, Grossi A, Paoletti F, Rafanelli D, Bacci P, Ferrini PR.
    Exp Hematol; 1992 Dec 15; 20(11):1296-301. PubMed ID: 1493858
    [Abstract] [Full Text] [Related]

  • 10. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
    Akel S, Bertolette D, Petrow-Sadowski C, Ruscetti FW.
    Platelets; 2007 Dec 15; 18(8):566-78. PubMed ID: 18041647
    [Abstract] [Full Text] [Related]

  • 11. Depletion of sodium butyrate from the culture medium of Friend erythroleukemia cells undergoing differentiation.
    Friend C, Zajac-Kaye M, Holland JG, Pogo BG.
    Cancer Res; 1987 Jan 15; 47(2):378-82. PubMed ID: 3466690
    [Abstract] [Full Text] [Related]

  • 12. Combination cytotoxic-differentiation therapy of mouse erythroleukemia cells with 5-fluorouracil and hexamethylene bisacetamide.
    Waxman S, Scher BM, Hellinger N, Scher W.
    Cancer Res; 1990 Jul 01; 50(13):3878-87. PubMed ID: 2354439
    [Abstract] [Full Text] [Related]

  • 13. [Function, molecular structure and gene expression regulation of erythroid differentiation factor (EDF/activin A)].
    Shiozaki M, Eto Y.
    Nihon Rinsho; 1992 Aug 01; 50(8):1950-5. PubMed ID: 1331567
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Structural characterization of erythroid and megakaryocytic differentiation in Friend erythroleukemia cells.
    Hyman T, Rothmann C, Heller A, Malik Z, Salzberg S.
    Exp Hematol; 2001 May 01; 29(5):563-71. PubMed ID: 11376868
    [Abstract] [Full Text] [Related]

  • 20. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
    Hafid-Medheb K, Poindessous-Jazat V, Augery-Bourget Y, Hanania N, Robert-Lézénès J.
    Cell Death Differ; 1999 Feb 01; 6(2):166-74. PubMed ID: 10200563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.